04:46 PM EDT, 03/27/2024 (MT Newswires) -- The Oncology Institute ( TOI ) reported a Q4 loss late Wednesday of $0.21 per diluted share, compared with a loss of $0.16 a year earlier.

GAAP EPS was not available on Capital IQ for comparison.

Operating revenue for the quarter that ended Dec. 31 was $85.8 million, up from $71.4 million a year earlier.

One analyst surveyed by Capital IQ expected $82 million.

The company expects full-year 2024 revenue of $400 million to $415 million. One analyst polled by Capital IQ expects $378.8 million.

The company shares were down more than 6% in after-hours activity.

Price: 1.72, Change: -0.12, Percent Change: -6.52